Submissions for variant NM_000059.3(BRCA2):c.323A>G (p.Asn108Ser) (rs80358568)

Minimum review status:		Collection method:
Minimum conflict level:
		ClinVar version:

Total submissions: 8

Download table as spreadsheet

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Ambry Genetics	RCV000166938	SCV000217758	uncertain significance	Hereditary cancer-predisposing syndrome	2016-05-06	criteria provided, single submitter	clinical testing	Lines of evidence used in support of classification: Insufficient or conflicting evidence
Breast Cancer Information Core (BIC) (BRCA2)	RCV000077298	SCV000146593	uncertain significance	Breast-ovarian cancer, familial 2	1998-06-22	no assertion criteria provided	clinical testing
Color	RCV000166938	SCV000683538	uncertain significance	Hereditary cancer-predisposing syndrome	2018-09-16	criteria provided, single submitter	clinical testing
Counsyl	RCV000077298	SCV000488230	uncertain significance	Breast-ovarian cancer, familial 2	2016-02-08	criteria provided, single submitter	clinical testing
GeneDx	RCV000221445	SCV000279279	uncertain significance	not provided	2018-05-16	criteria provided, single submitter	clinical testing	This variant is denoted BRCA2 c.323A>G at the cDNA level, p.Asn108Ser (N108S) at the protein level, and results in the change of an Asparagine to a Serine (AAT>AGT). Using alternate nomenclature, this variant would be defined as BRCA2 551A>G. This variant was observed in an individual during a validation study of a high-throughput protocol for variant identification; however, no clinical information was provided (Hondow 2011). BRCA2 Asn108Ser was not observed at a significant allele frequency in large population cohorts (Lek 2016). This variant is not located in a known functional domain. In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether BRCA2 Asn108Ser is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.
Illumina Clinical Services Laboratory,Illumina	RCV000315720	SCV000383610	uncertain significance	Fanconi anemia	2016-06-14	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000375006	SCV000383611	uncertain significance	Hereditary breast and ovarian cancer syndrome	2016-06-14	criteria provided, single submitter	clinical testing
Sharing Clinical Reports Project (SCRP)	RCV000077298	SCV000109095	uncertain significance	Breast-ovarian cancer, familial 2	2013-10-07	no assertion criteria provided	clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.